Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations
- PMID: 18574358
- DOI: 10.1097/AJP.0b013e31816b2f43
Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations
Abstract
Opioid-induced hyperalgesia (OIH) is most broadly defined as a state of nociceptive sensitization caused by exposure to opioids. The state is characterized by a paradoxical response whereby a patient receiving opioids for the treatment of pain may actually become more sensitive to certain painful stimuli. The type of pain experienced may or may not be different from the original underlying painful condition. Although the precise molecular mechanism is not yet understood, it is generally thought to result from neuroplastic changes in the peripheral and central nervous systems that lead to sensitization of pronociceptive pathways. OIH seems to be a distinct, definable, and characteristic phenomenon that may explain loss of opioid efficacy in some cases. Clinicians should suspect expression of OIH when opioid treatment effect seems to wane in the absence of disease progression, particularly if found in the context of unexplained pain reports or diffuse allodynia unassociated with the pain as previously observed. This review highlights the important mechanistic underpinnings and clinical ramifications of OIH and discusses future research directions and the latest clinical evidence for modulation of this potentially troublesome clinical phenomenon.
Similar articles
-
A comprehensive review of opioid-induced hyperalgesia.Pain Physician. 2011 Mar-Apr;14(2):145-61. Pain Physician. 2011. PMID: 21412369 Review.
-
Opioid-Induced Hyperalgesia in the Nonsurgical Setting: A Systematic Review.Am J Ther. 2019 May/Jun;26(3):e397-e405. doi: 10.1097/MJT.0000000000000734. Am J Ther. 2019. PMID: 29726847
-
Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats.J Opioid Manag. 2011 Sep-Oct;7(5):377-89. doi: 10.5055/jom.2010.0079. J Opioid Manag. 2011. PMID: 22165037
-
Clinical interpretation of opioid tolerance versus opioid-induced hyperalgesia.J Opioid Manag. 2014 Nov-Dec;10(6):383-93. doi: 10.5055/jom.2014.0235. J Opioid Manag. 2014. PMID: 25531956
-
Opioid induced hyperalgesia: clinical implications for the pain practitioner.Pain Physician. 2009 May-Jun;12(3):679-84. Pain Physician. 2009. PMID: 19461836 Review.
Cited by
-
Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.Pain. 2016 Aug;157(8):1773-1782. doi: 10.1097/j.pain.0000000000000581. Pain. 2016. PMID: 27075428 Free PMC article.
-
The importance of communication in the management of postoperative pain.Hawaii J Med Public Health. 2013 Jun;72(6):180-4. Hawaii J Med Public Health. 2013. PMID: 23795326 Free PMC article. Clinical Trial.
-
Remifentanil-Induced Secondary Hyperalgesia Is Not Prevented By Preoperative Acetazolamide Administration In Patients Undergoing Total Thyroidectomy: A Randomized Controlled Trial.J Pain Res. 2019 Nov 6;12:2991-2997. doi: 10.2147/JPR.S221131. eCollection 2019. J Pain Res. 2019. PMID: 31807056 Free PMC article.
-
High concentrations of morphine sensitize and activate mouse dorsal root ganglia via TRPV1 and TRPA1 receptors.Mol Pain. 2009 Apr 16;5:17. doi: 10.1186/1744-8069-5-17. Mol Pain. 2009. PMID: 19371406 Free PMC article.
-
Sufentanil Alleviates Intrathecal Lidocaine Induced Prolonged Sensory and Motor Impairments but not the Spinal Histological Injury in Rats.Neurochem Res. 2018 May;43(5):1104-1110. doi: 10.1007/s11064-018-2524-9. Epub 2018 Apr 27. Neurochem Res. 2018. PMID: 29704143
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
